The NextPharma site in Tampere is a centre of excellence for the development, commercial manufacturing and packaging of ophthalmic dosage forms with all the skills and equipment to handle all the development and tech transfer steps of your product.

The NextPharma Tampere site was recently acquired in 2019. The team has long-standing expertise in the manufacturing of ophthalmic dosage forms, including Blow fill seal unidose and multidose, 3P products and PFMD devices. Within a dedicated facility with flexible and high quality standard production system, NextPharma is able to satisfy a wide range of customer requirements. NextPharma as part of the acquisition has launched an investment program that has been initiated with a full new high-speed line for BFS unidose.


Manufacturing Capabilities:

  • BFS unidose and multidose
  • 3P technologies
  • PFMD devices